Science
CRISPR-based malaria therapy enters first human trial in Ghana
A one-shot gene therapy aims to make patients resistant to the parasite at the red-blood-cell stage.
WorldHouse Desk·June 29, 2026, 11:00 pm·1 min read
ACCRA — The Phase 1 trial will enrol 40 adults at two sites. Researchers hope to read out preliminary safety data within nine months.